- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 884
LivingSocial gets a bonus
The acquisition of Spain-based peer Let's Bonus for an undisclosed amount makes LivingSocial active in 10 countries with more than 16 million subscribers providing an expected $500m in turnover this year.
Jan 14, 2011Merck buys into Vaximm protection
Merck Serono Ventures joined venture capital firms Sunstone Capital, and BioMedPartners as new investors in Vaximm's latest $8m round.
Jan 13, 2011Holtzbrinck backs Proximic
Proximic raised $4.4m for its series C round from Holtzbrinck's corporate venturing unit and venture capital firm Wellington Partners.
Jan 11, 2011Investors sail away from OceanSaver
BW and Investinor provide exit for OceanSaver's investors.
Jan 9, 2011Symphogen for Europe's largest drugs round
Novo, a $20bn quasi-corporate venturing investment company wholly owned by the Novo Nordisk Foundation, is leading a $130m round for Symphogen.
Jan 7, 2011Shire steps into DBV's C round
InnoBio Fund and Lundbeckfond Ventures lead $25.5m round for DBV Technologies, which includes Shire.
Jan 6, 2011Shire agrees first venturing deal
Drugs group Shire gains management commitment to corporate venturing.
Jan 4, 2011Case study: Intelligent Energy
Intelligent Energy shows it has the power to push forward in renewable energy with its fuel cells for multiple transport and other purposes.
Jan 3, 2011About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


